Human Bone Marrow Mesenchymal Stem Cells: A Systematic Reappraisal Via the Genostem Experience

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 32-42

  Charbord, Pierre ^a   Livne, Erella ^b   Gross, Gerhard ^c   Häupl, Thomas ^d   Neves, Nuno M ^e   Marie, Pierre ^f   Bianco, Paolo ^g   Jorgensen, Christian ^h  

^a BICÊTRE HOSPITAL   (France)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF MINHO   (Portugal)

^f INSERM   (France)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h HÔPITAL SAINT ELOI   (France)

Author keywords

Bone; Cartilage; Differentiation; Regenerative medicine; Smooth muscle; Stem cell; Tendon

Indexed keywords

ANIMALIA;

EID: 78751706417     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9125-6     Document Type: Review

References (44)

1. Delorme, B., & Charbord, P. (2007). Culture and characterization of human bone marrow mesenchymal stem cells. Methods in Molecular Medicine, 140, 67-81.
2. Dimitriou, H., Linardakis, E., Martimianaki, G., et al. (2008). Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy, 10(2), 125-133.
3. Delorme, B., Ringe, J., Pontikoglou, C., et al. (2009). Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells, 27(5), 1142-1151.
4. Peiffer, I., Eid, P., Barbet, R., et al. (2007). A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon alpha/beta. Leukemia, 21(4), 714-724.
5. Delorme, B., Ringe, J., Gallay, N., et al. (2008). Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood, 111(5), 2631-2635.
6. Sacchetti, B., Funari, A., Michienzi, S., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 131(2), 324-336.
7. Kaltz, N., Funari, A., Hippauf, S., et al. (2008). In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells, 26(9), 2419-2424.
8. Galmiche, M. C., Koteliansky, V. E., Briere, J., Herve, P., & Charbord, P. (1993). Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood, 82(1), 66-76.
9. Bianco, P., & Gehron Robey, P. (2000). Marrow stromal stem cells. J Clin Invest, 105(12), 1663-1668.
10. Song, L., Webb, N. E., Song, Y., & Tuan, R. S. (2006). Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells, 24(7), 1707-1718.
11. Takashima, Y., Era, T., Nakao, K., et al. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell, 129(7), 1377-1388.
12. Ogawa, M., LaRue, A. C., & Drake, C. J. (2006). Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood, 108(9), 2893-2896.
13. Bianco, P., Robey, P. G., & Simmons, P. J. (2008). Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell, 2(4), 313-319.
14. Marie, P. J., & Fromigue, O. (2006). Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med, 1(4), 539-548.
15. Hamidouche, Z., Hay, E., Vaudin, P., et al. (2008). FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. Faseb Journal, 22(11), 3813-3822.
16. Hamidouche, Z., Fromigue, O., Ringe, J., et al. (2009). Priming integrin {alpha}5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci USA.
17. Djouad, F., Bony, C., Canovas, F., et al. (2009). Transcriptomic analysis identifies Foxo3A as a novel transcription factor regulating mesenchymal stem cell chrondrogenic differentiation. Cloning Stem Cells, 11(3), 407-416.
18. Djouad, F., Delorme, B., Maurice, M., et al. (2007). Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Research and Therapy, 9(2), R33.
19. Mrugala, D., Dossat, N., Ringe, J., et al. (2009). Gene expression profile of multipotent mesenchymal stromal cells: Identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells, 11(1), 61-76.
20. Boyer, M. I., Goldfarb, C. A., & Gelberman, R. H. (2005). Recent progress in flexor tendon healing. The modulation of tendon healing with rehabilitation variables. Journal of Hand Therapy, 18(2), 80-85. quiz 6.
21. Hoffmann, A., Pelled, G., Turgeman, G., et al. (2006). Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. Journal of Clinical Investigation, 116(4), 940-952.
22. Correlo, V. M., Pinho, E. D., Pashkuleva, I., Bhattacharya, M., Neves, N. M., & Reis, R. L. (2007). Water absorption and degradation characteristics of chitosan-based polyesters and hydroxyapatite composites. Macromolecular Bioscience, 7(3), 354-363.
23. Costa-Pinto, A. R., Salgado, A. J., Correlo, V. M., et al. (2008). Adhesion, proliferation, and osteogenic differentiation of a mouse mesenchymal stem cell line (BMC9) seeded on novel melt-based chitosan/polyester 3D porous scaffolds. Tissue Engineering Part A, 14(6), 1049-1057.
24. Oliveira, J. T., Correlo, V. M., Sol, P. C., et al. (2008). Assessment of the suitability of chitosan/polybutylene succinate scaffolds seeded with mouse mesenchymal progenitor cells for a cartilage tissue engineering approach. Tissue Engineering Part A, 14(10), 1651-1661.
25. Costa-Pinto, A. R., Correlo, V. M., & Sol, P. C., et al. (2009). Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Seeded on Melt Based Chitosan Scaffolds for Bone Tissue Engineering Applications. Biomacromolecules, 10(8), 2067-2073.
26. Roman, I., Vilalta, M., Rodriguez, J., et al. (2007). Analysis of progenitor cell-scaffold combinations by in vivo non-invasive photonic imaging. Biomaterials, 28(17), 2718-2728.
27. Srouji, S., Kizhner, T., Ben David, D., Riminucci, M., Bianco, P., & Livne, E. (2009). The Schneiderian membrane contains osteoprogenitor cells: in vivo and in vitro study. Calcified Tissue International, 84(2), 138-145.
28. Mrugala, D., Bony, C., Neves, N., et al. (2008). Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Annals of the Rheumatic Diseases, 67(3), 288-295.
29. Snedeker, J. G., Arav, A. B., Zilberman, Y., Pelled, G., & Gazit, D. (2009). Functional Fibered Confocal Microscopy: A Promising Tool for Assessing Tendon Regeneration. Tissue Eng Part C Methods, 15(3), 485-491.
30. Snedeker, J. G., Pelled, G., Zilberman, Y., et al. (2008). An Analytical Model for Elucidating Tendon Tissue Structure and Biomechanical Function from in vivo Cellular Confocal Microscopy Images. Cells Tissues Organs, 190(2), 111-119.
31. Snedeker, J. G., Pelled, G., Zilberman, Y., Gerhard, F., Muller, R., & Gazit, D. (2006). Endoscopic cellular microscopy for in vivo biomechanical assessment of tendon function. Journal of Biomedical Optics, 11(6), 064010.
32. Jones, P. H., Simons, B. D., & Watt, F. M. (2007). Sic transit gloria: farewell to the epidermal transit amplifying cell? Cell Stem Cell, 1(4), 371-381.
33. Zipori, D. (2005). The stem state: plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells, 23(6), 719-726.
34. Huang, S. (2009). Reprogramming cell fates: reconciling rarity with robustness. Bioessays, 31(5), 546-560.
35. Dezawa, M., Ishikawa, H., Itokazu, Y., et al. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science, 309(5732), 314-317.
36. Dezawa, M., Kanno, H., Hoshino, M., et al. (2004). Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. Journal of Clinical Investigation, 113(12), 1701-1710.
37. Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell, 1(1), 39-49.
38. Slack, J. M. (2007). Metaplasia and transdifferentiation: from pure biology to the clinic. Nature Reviews Molecular Cell Biology, 8(5), 369-378.
39. Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell, 126(4), 677-689.
40. Granero-Molto, F., Weis, J. A., Miga, M. I., et al. (2009). Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells, 27(8), 1887-1898.
41. Kinnaird, T., Stabile, E., Burnett, M. S., et al. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109(12), 1543-1549.
42. da Silva Meirelles, L., Caplan, A. I., & Nardi, N. B. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells, 26(9), 2287-2299.
43. Noel, D., Caton, D., Roche, S., et al. (2008). Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Experimental Cell Research, 314(7), 1575-1584.
44. Towler, D. A., & Gelberman, R. H. (2006). The alchemy of tendon repair: a primer for the (S)mad scientist. Journal of Clinical Investigation, 116(4), 863-866.